Hard-to-heal wounds represent a major Issue; medically, economically and pshycologically.
In many cases especially diabetic patients, the end solution is to amputate the wounded limb.
Roughly 50% of Diabetic Foot Ulcers become infected and about one in five of these patients will undergo a lower extremity amputation (LEA). In 2016 130,000 Americans were hospitalized for a LEA.
In Israel, around 75% of LEA’s are among diabetic patients and every year there are at least 1,500 LEA’s. The related economic burden is heavy. With effective treatment, many amputations can be prevented.
K-Sept 1000 provides powerful debridement. The patented K-Sept blue solution acts by softening of necrotic tissue, prevention of microbial growth, debris removal and exudate absorption.
K-Sept 1000 is supported by vast clinical experience. It comes in a box of 25 effervescent tablets and registered for “debridement, irrigation, hygiene and cleaning for wounds & skin”.
K-Sept 1000, with its powerful debridement capability, facilitates the critical shift from Inflammation to Granulation, thus paving the way to wound healing.
By Scope and Severity, by Economic Burden, by Psychosocial Impact
Effective – Safe – Proven – Easy to Use
Continuous renewal of solution on the wound (via frequent dressing wetting) is essential for facilitating wound healing.
For Treatment Examples with K-Sept 1000 (Before & After Images) –
For preparing the K-Sept 1000 solution, you can use K-Sept designated filling bottles. These 1 Liter bottles come with ready labels and 2 forms of closure, cap and sprayer. This enables pouring or spraying, as preferred by the practitioner. The filling bottles have been lab tested and found suitable for their purpose. They ensure consistency of practice in the clinical setting and – via the ready label – assist in avoiding identification mistakes. There is also a designated space for adding the date of preparing the solution (thus ensuring use within the recommended time frame of 48H after preparation).